title: Opportunities in somatostatin research: biological, chemical and therapeutic aspects.
authors.affiliation: Transplantation and Immunology, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland. gisbert.weckbecker@pharma.novartis.com
authors.forename: Gisbert
authors.initials: G
authors.lastname: Weckbecker
authors.forename: Ian
authors.initials: I
authors.lastname: Lewis
authors.forename: Rainer
authors.initials: R
authors.lastname: Albert
authors.forename: Herbert A
authors.initials: HA
authors.lastname: Schmid
authors.forename: Daniel
authors.initials: D
authors.lastname: Hoyer
authors.forename: Christian
authors.initials: C
authors.lastname: Bruns
mesh_terms: D000172:Acromegaly / Q000188:drug therapy / Q000378:metabolism; D000818:Animals; D035843:Biomedical Research / Q000379:methods*; D004701:Endocrine Gland Neoplasms / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D015394:Molecular Structure; D011986:Receptors, Somatotropin / Q000737:chemistry / Q000378:metabolism* / Q000502:physiology; D015398:Signal Transduction; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use*
chemical_list: D011986:Receptors, Somatotropin; D013004:Somatostatin